Medical Cannabis for Pain Presentations
List topics and panel discussion here
PHILIPPE LUCAS PhD(c)
Philippe is the Vice President, Global Patient Research and Access at Tilray, a federally authorized medical cannabis production, research and distribution company based in Nanaimo, BC; Vice-Chair of the Cannabis Canada Council; and a Graduate Researcher with the Canadian Institute for Substance Use Research. His scientific research includes the therapeutic use of cannabis in the treatment of mental health conditions and addiction, and he has been invited to provide expert testimony before the Canadian House of Commons, the Canadian Senate, and the BC Supreme Court.
Philippe first became involved with medical cannabis as a patient, and founded the Vancouver Island Compassion Society in 1999 to serve the needs of patients who might benefit from the medical use of cannabis. He is extremely community involved, and served as a Victoria City Councillor and Regional Director from 2008-2011.
Philippe has received a number of accolades and awards for his work, including the Queen Elizabeth II Diamond Jubilee Medal (2013) for his work and research on medical cannabis, and a Lifetime Achievement Award from the Cannabis Canada Council (2018).
DR. ROB TANGUAY MD FRCPC CISAM CCSAM
President-Elect, Pain Society of Alberta
Alberta Pain Strategy - Opioid Working Group Chair
Dr. Rob Tanguay an FRCPC psychiatrist who is fellowship trained and sub-specialized in both Addiction Medicine, certified under the International Society of Addiction’s Medicine (ISAM) and Canadian Society of Addiction’s Medicine (CSAM), and Pain Medicine. He is the Provincial Medical Lead for Opioid Dependency Treatment Training for Addictions and Mental Health, Alberta Health Services, the Executive Director of the Canadian Opioid Deprescibing Institute (CODi), the Executive Director of the Transitional Outpatient Patient Program for Pain (TOPPS), the President Elect of the Pain Society of Alberta, the CSAM Regional Director for Alberta and NWT, and the Co-Chair of the Opioid Use in Pain Medicine working group for the Alberta Pain Strategy. Dr. Tanguay’s current clinical positions include: Medical Lead of the TOPPS clinic (Transitional Outpatient Pain Program for Spine), Medical Lead of the Canadian Deprescribing Institute, and a Pain, Psychiatric, and Addictions Consultant for the Opioid Deprescribing Program, Alberta Health Services. He has been invited to be a keynote, plenary, and panel speaker at national and international conferences as well as for local events and is a Clinical Lecturer at the Cumming School of Medicine, University of Calgary.
DR. MARK A. WARE MBBS MRCP(UK) MSc
Chief Medical Officer, Canopy Growth Corporation
Associate Professor, Depts. of Family Medicine and Anesthesia, McGill University
Dr. Mark Ware is currently the Chief Medical Officer of Canopy Growth Corporation. He has taken a leave of absence as Associate Professor in Family Medicine and Anesthesia at McGill University from July 2018 to work in this capacity. He previously served as Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre for over 10 years, and was the Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids since 2007. He has served as co-director of the FRQS-supported Quebec Pain Research Network, and sat on the executive management team of the Alan Edwards Centre for Research on Pain at McGill University.
His research has been funded and supported by CIHR, FRQS, private foundations and pharmaceutical companies. He has published over 100 papers on cannabis and pain research inacademic journals, has written 6 book chapters, and has given hundreds of lectures to health professionals and the public on cannabis over the last 20 years. He has served as a consultant to several large corporate and academic research programs internationally. He has advised the Canadian federal government on cannabis policy since 2001, and 2016, he served as the vice chair of the Federal Task Force on the Legalization and Regulation of Cannabis in Canada.
can we add company website links to the top tier exhibitors?